S&P 500 Futures
(-0.06%) 5 143.75 points
Dow Jones Futures
(-0.02%) 38 550 points
Nasdaq Futures
(0.01%) 17 905 points
Oil
(-0.22%) $82.45
Gas
(1.67%) $2.06
Gold
(-1.03%) $2 333.30
Silver
(-2.10%) $27.08
Platinum
(-0.52%) $956.50
USD/EUR
(0.15%) $0.934
USD/NOK
(0.33%) $11.02
USD/GBP
(0.21%) $0.798
USD/RUB
(-0.23%) $93.09

实时更新: BioAtla, Inc. [BCAB]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
BUY
33.33%
return -2.90%
SELL
33.33%
return 8.19%
最后更新时间30 Apr 2024 @ 04:00

1.57% $ 2.58

出售 108989 min ago

@ $2.35

发出时间: 14 Feb 2024 @ 22:33


回报率: 9.79%


上一信号: Feb 12 - 23:14


上一信号: 购买


回报率: -12.31 %

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 04:00):

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer...

Stats
今日成交量 465 712
平均成交量 550 124
市值 124.11M
EPS $0 ( 2024-03-26 )
下一个收益日期 ( $-0.570 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.000
ATR14 $0.00400 (0.15%)
Insider Trading
Date Person Action Amount type
2024-03-31 Smith Scott Andrew Sell 2 181 Common Stock
2024-03-31 Sievers Eric Sell 572 Common Stock
2024-02-29 Smith Scott Andrew Sell 2 181 Common Stock
2024-02-29 Sievers Eric Sell 572 Common Stock
2024-02-15 Waldron Richard A Buy 106 000 Common Stock
INSIDER POWER
93.82
Last 100 transactions
Buy: 3 003 180 | Sell: 92 181

音量 相关性

長: -0.12 (neutral)
短: -0.20 (neutral)
Signal:(55.149) Neutral

BioAtla, Inc. 相关性

10 最正相关
GOSS0.966
ODT0.962
SWAV0.95
TRVN0.944
XFOR0.944
THTX0.941
PAVM0.935
LYRA0.933
TCDA0.931
ENPH0.931
10 最负相关
MLCO-0.965
ITMR-0.954
AVEO-0.95
CCRC-0.946
TOUR-0.946
LUNA-0.941
ACAB-0.938
TCMD-0.937
RXDX-0.937
ALXN-0.937

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

BioAtla, Inc. 相关性 - 货币/商品

The country flag 0.82
( strong )
The country flag 0.85
( strong )
The country flag 0.00
( neutral )
The country flag 0.61
( weak )
The country flag -0.09
( neutral )
The country flag -0.81
( strong negative )

BioAtla, Inc. 财务报表

Annual 2023
营收: $0
毛利润: $-1.22M (0.00 %)
EPS: $-2.58
FY 2023
营收: $0
毛利润: $-1.22M (0.00 %)
EPS: $-2.58
FY 2022
营收: $0
毛利润: $-1.20M (0.00 %)
EPS: $-2.70
FY 2021
营收: $250 000
毛利润: $250 000 (100.00 %)
EPS: $0

Financial Reports:

No articles found.

BioAtla, Inc.

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。